Live Breaking News & Updates on Refractory Angina

Stay updated with breaking news from Refractory angina. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gene therapy treatment increasing body's signal for new blood vessel growth shows promise

Gene therapy treatment increasing body's signal for new blood vessel growth shows promise
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , Kenta Nakamura , Thomasj Povsic , Society For Cardiovascular Angiography Interventions , Interventional Cardiologist At Duke University Medical Center , University Of Washington Medical Center , Cardiovascular Angiography , Interventional Cardiologist , Duke University Medical Center , Washington Medical Center , Therapy Improves Exercise Time , Refractory Angina ,

Coronary sinus reducer relieves angina, but how it works remains unclear

Coronary sinus reducer relieves angina, but how it works remains unclear
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , Michael Foley , Rasha Al Lamee , Michaelj Foley , Drug Administration , Imperial College Healthcare , American College Of Cardiology Annual Scientific Session , Imperial College London , American College , Annual Scientific , Seattle Angina Questionnaire , Sinus Reducer , Refractory Angina , Placebo Controlled Trial ,

Shockwave Reducer Demonstrates Consistent, Positive Results in 'Real-World' Study

Six-Month Results from REDUCER-I Trial Add to Positive Evidence of the Coronary Sinus Reducer to Treat Refractory AnginaSANTA CLARA, Calif., April 08, 2024 (GLOBE NEWSWIRE) Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced that investigators presented six-month data from the full population of the REDUCER-I study, alongside interim long-term follow-up results ....

United Kingdom , United States , De Hoef , Noord Holland , City Of , Stefan Verheye , Scott Shadiow , Michael Foley , Debbie Kaster , Rasha Al Lamee , European Union , Lung Institute , Imperial College , National Heart , Shockwave Medical Inc , Canadian Cardiovascular Society , University Medical Center Utrecht , Exchange Commission , Six Month Results , Trial Add , Positive Evidence , Coronary Sinus Reducer , Treat Refractory , Shockwave Reducer , Annual Scientific Sessions , American College ,